Advertisement

Topics

Cantargia: Phase I Safety Evaluation Part of CANFOUR Trial of Antibody CAN04 Completed and Phase IIa Part Being Initiated

09:40 EST 7 Dec 2018 | FinanzNachrichten

STOCKHOLM, Dec 7, 2018 /PRNewswire/ -- Cantargia AB (publ) today announces that all patients in the phase I part of the CANFOUR clinical trial have completed the formal safety evaluation phase of ...

Original Article: Cantargia: Phase I Safety Evaluation Part of CANFOUR Trial of Antibody CAN04 Completed and Phase IIa Part Being Initiated

NEXT ARTICLE

More From BioPortfolio on "Cantargia: Phase I Safety Evaluation Part of CANFOUR Trial of Antibody CAN04 Completed and Phase IIa Part Being Initiated"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...